Masimo EBITDA 2007-2019 | MASI

Masimo annual and quarterly EBITDA history from 2007 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Masimo EBITDA for the quarter ending June 30, 2019 was $0.058B, a 1.86% increase year-over-year.
  • Masimo EBITDA for the twelve months ending June 30, 2019 was $0.233B, a 8.32% increase year-over-year.
  • Masimo 2018 annual EBITDA was $0.229B, a 12.42% increase from 2017.
  • Masimo 2017 annual EBITDA was $0.204B, a 54.98% decline from 2016.
  • Masimo 2016 annual EBITDA was $0.453B, a 233.07% increase from 2015.
Masimo Annual EBITDA
(Millions of US $)
2018 $229
2017 $204
2016 $453
2015 $136
2014 $116
2013 $91
2012 $95
2011 $94
2010 $113
2009 $88
2008 $77
2007 $72
2006 $313
2005 $12
Masimo Quarterly EBITDA
(Millions of US $)
Q2 2019 $58
Q1 2019 $61
Q4 2018 $59
Q3 2018 $54
Q2 2018 $57
Q1 2018 $59
Q4 2017 $50
Q3 2017 $48
Q2 2017 $49
Q1 2017 $57
Q4 2016 $330
Q3 2016 $41
Q2 2016 $41
Q1 2016 $41
Q4 2015 $41
Q3 2015 $32
Q2 2015 $32
Q1 2015 $31
Q4 2014 $36
Q3 2014 $26
Q2 2014 $21
Q1 2014 $33
Q4 2013 $16
Q3 2013 $24
Q2 2013 $26
Q1 2013 $26
Q4 2012 $25
Q3 2012 $20
Q2 2012 $25
Q1 2012 $24
Q4 2011 $22
Q3 2011 $21
Q2 2011 $24
Q1 2011 $27
Q4 2010 $23
Q3 2010 $24
Q2 2010 $23
Q1 2010 $42
Q4 2009 $23
Q3 2009 $22
Q2 2009 $22
Q1 2009 $22
Q4 2008 $22
Q3 2008 $22
Q2 2008 $18
Q1 2008 $15
Q4 2007 $18
Q3 2007 $18
Q2 2007 $20
Q1 2007 $17
Q3 2006 $21
Q2 2006 $22
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.756B $0.858B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $113.591B 24.20
Intuitive Surgical (ISRG) United States $59.705B 52.22
Edwards Lifesciences (EW) United States $47.232B 45.97
IDEXX Laboratories (IDXX) United States $23.830B 59.78
Fresenius Medical Care AG KGaA (FMS) Germany $20.090B 13.48
Olympus (OCPNY) Japan $18.383B 0.00
Teleflex (TFX) United States $14.891B 31.61
SONOVA HOLDING (SONVY) Switzerland $14.646B 0.00
DexCom (DXCM) United States $14.166B 209.93
Sysmex ADR (SSMXY) Japan $13.579B 36.55
Hologic (HOLX) United States $13.042B 20.59
STERIS (STE) Ireland $11.914B 27.48
Varian Medical Systems (VAR) United States $10.091B 24.14
ABIOMED (ABMD) United States $7.698B 44.06
SARTORIUS AG (SARTF) Germany $5.614B 49.88
Integra LifeSciences Holdings (IART) United States $5.204B 23.22
Penumbra (PEN) United States $5.078B 182.43
Globus Medical (GMED) United States $5.001B 31.74
Elekta AB (EKTAY) Sweden $4.688B 36.09
LivaNova (LIVN) United Kingdom $3.431B 26.16
Tandem Diabetes Care (TNDM) United States $3.316B 0.00
Cantel Medical (CMD) United States $2.888B 29.17
Wright Medical Group (WMGI) Netherlands $2.584B 226.67
Nihon Kohden (NHNKY) Japan $2.578B 25.94
Nevro (NVRO) United States $2.519B 0.00
Integer Holdings (ITGR) United States $2.443B 17.28
Glaukos (GKOS) United States $2.246B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.886B 34.99
OPKO Health (OPK) United States $1.262B 0.00
Veracyte (VCYT) United States $1.226B 0.00
Inogen (INGN) United States $1.067B 26.17
Natus Medical (NTUS) United States $1.040B 24.23
ORTHOFIX MEDICAL INC (OFIX) United States $0.993B 31.19
Accelerate Diagnostics (AXDX) United States $0.981B 0.00
Mesa Laboratories (MLAB) United States $0.963B 40.04
Silk Road Medical (SILK) United States $0.958B 0.00
Luminex (LMNX) United States $0.896B 0.00
Corindus Vascular Robotics (CVRS) United States $0.889B 0.00
CryoLife (CRY) United States $0.872B 83.04
Tactile Systems Technology (TCMD) United States $0.848B 104.81
Pacific Biosciences Of California (PACB) United States $0.785B 0.00
Intersect ENT (XENT) United States $0.549B 0.00
AngioDynamics (ANGO) United States $0.546B 19.62
OrthoPediatrics (KIDS) United States $0.523B 0.00
Quotient (QTNT) Switzerland $0.487B 0.00
AxoGen (AXGN) United States $0.459B 0.00
Si-Bone (SIBN) United States $0.416B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.410B 15.75
GenMark Diagnostics (GNMK) United States $0.313B 0.00
Sientra (SIEN) United States $0.306B 0.00
Alphatec Holdings (ATEC) United States $0.303B 0.00
Fluidigm (FLDM) United States $0.299B 0.00
Semler Scientific (SMLR) United States $0.261B 43.96
IRadimed (IRMD) United States $0.246B 40.91
ViewRay (VRAY) United States $0.241B 0.00
Accuray (ARAY) United States $0.237B 0.00
CRH Medical (CRHM) Canada $0.220B 76.25
Stereotaxis (STXS) United States $0.215B 0.00
SeaSpine Holdings (SPNE) United States $0.204B 0.00
RTI Surgical (RTIX) United States $0.198B 29.78
Neuronetics (STIM) United States $0.164B 0.00
ConforMIS (CFMS) United States $0.152B 0.00
EDAP TMS S.A (EDAP) France $0.134B 66.00
T2 Biosystems (TTOO) United States $0.114B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
TransEnterix (TRXC) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Spectral Diagnostics (EDTXF) Canada $0.070B 0.00
Apollo Endosurgery (APEN) United States $0.058B 0.00
Electromed (ELMD) United States $0.055B 28.26
Helius Medical Technologies (HSDT) United States $0.040B 0.00
Ekso Bionics Holdings (EKSO) United States $0.039B 0.00
Bioanalytical Systems (BASI) United States $0.039B 0.00
Vermillion (VRML) United States $0.037B 0.00
Xtant Medical Holdings (XTNT) United States $0.036B 0.00
Nuvectra (NVTR) United States $0.026B 0.00
Neovasc (NVCN) Canada $0.025B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.021B 0.00
Restoration Robotics (HAIR) United States $0.017B 0.00
Ra Medical Systems (RMED) United States $0.016B 0.00
Cesca Therapeutics (KOOL) United States $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.24
Nanovibronix (NAOV) United States $0.013B 0.00
DarioHealth (DRIO) Israel $0.012B 0.00
Lianluo Smart (LLIT) China $0.011B 0.00
OBALON THERPTCS (OBLN) United States $0.009B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Allied Healthcare Products (AHPI) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Avinger (AVGR) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.004B 0.00
InspireMD (NSPR) Israel $0.002B 0.00
Viveve Medical (VIVE) United States $0.002B 0.00